Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Syqe Medical

CTech 24/7

  • Full list of Israeli high-tech funding rounds in 2025
  • Coralogix raises $115 million Series E at over $1 billion valuation
  • Intel to lay off up to 20% of global factory workforce
  • HR on the frontline: How Israel’s tech sector is managing crisis
More stories in CTech

Syqe Medical

5 stories about Syqe Medical
  • כנס קנאביס canabiz פרי דוידסון סאייקי מדיקל

    Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650 million

    18.07.23|Sophie ShulmanThe Israeli company’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis

  • Syqe Medical founder and CEO Perry Davidson. Photo: Amit Sha'al

    For Medical Cannabis Users, the Biggest Problem Is a Consistent Dose, Says Syqe Medical CEO

    07.05.19|Orna YefetPerry Davidson, founder and CEO of cannabis inhaler company Syqe Medical, spoke Monday at Calcalist's cannabis conference in Tel Aviv

  • Syqe Medical founder Perry Davidson. Photo: Orel Cohen

    Cannabis Inhaler Company Syqe Medical Raises $50 Million

    01.01.19|Amarelle WenkertSyqe develops a pocket-sized metered-dose inhaler designed for precise delivery of cannabis molecules

  • Perry Davidson. Photo: Orel Cohen

    Plants Are the Future of Medicine, Says Syqe Medical Founder

    29.07.18|KPMG, a CTech partnerTransforming cannabis into precisely-dosed treatment has made it medically and financially legitimacy, says Perry Davidson, the founder of Syqe Medical, which developed a precise cannabis inhaler

  • Medical cannabis (illustration). Photo: Getty Images

    U.S. Money Flows Into Israeli Medical Cannabis Companies for Good Reason

    14.01.18|Keren Hagai and Joseph I. WyseWhile U.S. regulators hamper cannabis-related research, Israeli cannabis startups draw the attention of investors and collaborators

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive